Greater Cannabis Company (GCAN) Shareholder's Equity (2016 - 2026)

Greater Cannabis Company (GCAN) Shareholder's Equity (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 8.23 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.75 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.21 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 446.17 Mn
10 Greater Cannabis Company - - - -775,025.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -775,025.00
Dec 31, 2025 -741,649.00
Sep 30, 2025 -1.11 Mn
Jun 30, 2025 -1.07 Mn
Mar 31, 2025 -823,984.00
Dec 31, 2024 -840,273.00
Sep 30, 2024 -796,925.00
Jun 30, 2024 -750,760.00
Mar 31, 2024 -705,843.00
Dec 31, 2023 -661,232.00
Sep 30, 2023 -650,371.00
Jun 30, 2023 -632,941.00
Mar 31, 2023 -587,898.00
Dec 31, 2022 -544,830.00
Sep 30, 2022 -561,429.00
Jun 30, 2022 -641,653.00
Mar 31, 2022 -616,748.00
Dec 31, 2021 -469,062.00
Sep 30, 2021 -272,731.00
Jun 30, 2021 -86,452.00